Castilho L, Reid ME. A review of the JR blood group system. Immunohematology 2013;29:63–8.CastilhoLReidME.A review of the JR blood group system. Immunohematology2013;29:63–8.10.21307/immunohematology-2019-126Search in Google Scholar
Berardi P, Cote J, Vege S, et al. Two novel ABCG2 alleles resulting in a Jr(a–) phenotype. Transfusion 2017;57:2811–2.BerardiPCoteJVegeS, Two novel ABCG2 alleles resulting in a Jr(a–) phenotype. Transfusion2017;57:2811–2.10.1111/trf.1430228836283Search in Google Scholar
Tobita R, Kato S, Osabe T, et al. Genetic analysis of the Jr(a–) in Japanese people. Vox Sang 2013;105:230.TobitaRKatoSOsabeT, Genetic analysis of the Jr(a–) in Japanese people. Vox Sang2013;105:230.Search in Google Scholar
Ogasawara K, Osabe T, Susuki Y, et al. A new ABCG2 null allele with a 27-kb deletion including the promoter region causing the Jr(a–) phenotype. Transfusion 2015;55:1467–71.OgasawaraKOsabeTSusukiY, A new ABCG2 null allele with a 27-kb deletion including the promoter region causing the Jr(a–) phenotype. Transfusion2015;55:1467–71.10.1111/trf.1296925522810Search in Google Scholar
Tanaka M, Kamada I, Takahashi J, et al. Defining the Jr(a–) phenotype in the Japanese population. Transfusion 2014;54:412–7.TanakaMKamadaITakahashiJ, Defining the Jr(a–) phenotype in the Japanese population. Transfusion2014;54:412–7.Search in Google Scholar
Wieckhusen C, Rink G, Scharberg EA, et al. A new genetic background for the Jr(a–) blood group phenotype caused by the ABCG2*439T allele encoding a p.Arg147Trp change. Transfusion 2017;57:3063–4.WieckhusenCRinkGScharbergEA, A new genetic background for the Jr(a–) blood group phenotype caused by the ABCG2*439T allele encoding a p.Arg147Trp change. Transfusion2017;57:3063–4.10.1111/trf.1437529106709Search in Google Scholar
Saison C, Cartron J-P, Arnaud L. Deletion of exons 3 through 5 of ABCG2 causes the Jr(a–) phenotype in a West African woman. Transfusion 2015;55:2766–7.SaisonCCartronJ-PArnaudL.Deletion of exons 3 through 5 of ABCG2 causes the Jr(a–) phenotype in a West African woman. Transfusion2015;55:2766–7.10.1111/trf.1322326173500Search in Google Scholar
Hue-Roye K, Zelinski T, Cobaugh A, et al. The JR blood group system: identification of alleles that alter expression. Transfusion 2013;53:2710–4.Hue-RoyeKZelinskiTCobaughA, The JR blood group system: identification of alleles that alter expression. Transfusion2013;53:2710–4.10.1111/trf.1211823438071Search in Google Scholar
Hue-Roye K, Lomas-France C, Coghlan G, et al. The JR blood group system (ISBT 032): molecular characterization of three new null alleles. Transfusion 2013;53:1575–9.Hue-RoyeKLomas-FranceCCoghlanG, The JR blood group system (ISBT 032): molecular characterization of three new null alleles. Transfusion2013;53:1575–9.10.1111/j.1537-2995.2012.03930.x23066723Search in Google Scholar
Saison C, Helias V, Balif BA, et al. Null alleles of ABCG2 encoding the breast cancer resistance protein define the new blood group system Junior. Nat Genet 2012;44:174–7.SaisonCHeliasVBalifBA, Null alleles of ABCG2 encoding the breast cancer resistance protein define the new blood group system Junior. Nat Genet2012;44:174–7.10.1038/ng.1070365363122246505Search in Google Scholar
Zelinski T, Coghlan G, Xiao-Qing I, Reid ME. ABCG2 null alleles define the Jr(a–) blood group phenotype. Nat Genet 2012;44:131–2.ZelinskiTCoghlanGXiao-QingIReidME.ABCG2 null alleles define the Jr(a–) blood group phenotype. Nat Genet2012;44:131–2.10.1038/ng.107522246507Search in Google Scholar
Adams SM, Conley YP, Ren D, et al. ABCG2 c.421C>A is associated with outcomes after severe traumatic brain injury. J Neurotrauma 2018;35:48–53.AdamsSMConleyYPRenD, ABCG2 c.421C>A is associated with outcomes after severe traumatic brain injury. J Neurotrauma2018;35:48–53.10.1089/neu.2017.5000575707528747144Search in Google Scholar
Stiburkova B, Pavelcova K, Zavada J, et al. Functional non-synonymous variants of ABCG2 and gout risk. Rheumatology 2017;56:1982–92.StiburkovaBPavelcovaKZavadaJ, Functional non-synonymous variants of ABCG2 and gout risk. Rheumatology2017;56:1982–92.10.1093/rheumatology/kex29528968913Search in Google Scholar
Fujita S, Kashiwagi H, Tomimatsu T, et al. Expression levels of ABCG2 on cord red blood cells and study of fetal anemia associated with anti-Jra. Transfusion 2016;56:1171–81.FujitaSKashiwagiHTomimatsuT, Expression levels of ABCG2 on cord red blood cells and study of fetal anemia associated with anti-Jra. Transfusion2016;56:1171–81.10.1111/trf.1351526868047Search in Google Scholar
